We develop formulations for poorly water-soluble therapeutics
The majority of new chemical entities emerging from today's drug discovery pipelines are too poorly water-soluble to enable reproducible bioavailability and efficacy after oral intake. This greatly hinders drug development and ultimately prevents patients from accessing new treatments.
At Harpago, we tackle this solubility problem.
At Harpago, we tackle this solubility problem.
Why work with us ?
A specialist CDMO for drug solubility enhancement
- Technical focusSolubility enhancement is the
only thing we do. - Low overheadOur operational focus on early-phase formulation R&D allows us to increase agility and to work more
cost-effectively. - DedicationOur founders are still closely involved in the day-to-day operations and ensure that every project is approached with diligence and dedication.
Unlock the full therapeutic potential of your active compound.
Get in touch to discuss your solubility problem.
Get in touch to discuss your solubility problem.